Pyridone derivative, composition and use as antiviral drug thereof
PH12020551264B1Active Publication Date: 2026-09-16JIANGXI CAISHI PHARMA TECH CO LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12020551264
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-08-17
- Publication Date
- 2026-09-16
- Estimated Expiration
- 2040-08-17
Abstract
The present disclosure belongs to the field of medicinal chemistry, and relates to a novel pyridone derivative represented by Formula (I) or a stereoisomer, a pharmaceutically acceptable salt, a solvate or a crystal thereof, and use thereof in the preparation of a drug for preventing or treating diseases such as influenza type A viral infection and / or influenza type B viral infection, particularly use thereof as a PA subunit cap-dependent endonuclease inhibitor for preventing or treating diseases such as influenza type A viral infection and / or influenza type B viral infection. The compounds of the present disclosure have significant activity in inhibiting influenza endonuclease and influenza DNA, can be used either alone or in combination with a neuraminidase inhibitor, a nucleoside drug, a PB2 inhibitor, a PB1 inhibitor, an M2 inhibitor or other anti-influenza drugs, significantly shorten the time of influenza infection and reduces mortality, and have excellent clinical application prospects.
Need to check novelty before this filing date? Find Prior Art